Хайлтын үр дүнгүүд - Pratik S. Multani
- 15-н 1 - 15 үр дүнгүүдийг харуулж байна
-
1
-
2
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial -н Gregory A. Wiseman, Leo I. Gordon, Pratik S. Multani, Thomas E. Witzig, Stewart Spies, Nancy L. Bartlett, Russell J. Schilder, James L. Murray, Mansoor N. Saleh, R. S. Allen, Antonio J Grillo-López, Christine A. White
Хэвлэсэн 2002Artigo -
3
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for re... -н Thomas R. Spitzer, Steven L. McAfee, Robert Sackstein, Christine Colby, Han Chong Toh, Pratik S. Multani, Susan L. Saidman, Dina Weymouth, Frederic I. Preffer, Cathleen Poliquin, Alicia Foley, Benjamin F. Cox, David Andrews, David H. Sachs, Megan Sykes
Хэвлэсэн 2000Artigo -
4
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations -н Gang G. Li, Romel Somwar, James D. Joseph, Roger S. Smith, Takuo Hayashi, Leenus Martin, Aleksandra Franovic, Anni Schairer, Eric S. Martin, Gregory J. Riely, Jason Harris, Shunqi Yan, Wei Ge, Jennifer Oliver, Rupal Patel, Pratik S. Multani, Marc Ladanyi, Alexander Drilon
Хэвлэсэн 2016Artigo -
5
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer -н Alessio Amatu, Alessio Somaschini, Giulio Cerea, Roberta Bosotti, Emanuele Valtorta, Pasquale Buonandi, Giovanna Marrapese, Silvio Veronese, David Luo, Zachary Hornby, Pratik S. Multani, Danielle Murphy, Robert Shoemaker, Calogero Lauricella, Laura Giannetta, M. Maiolani, Angelo Vanzulli, Elena Ardini, Arturo Galvani, Antonella Isacchi, Andrea Sartore‐Bianchi, Salvatore Siena
Хэвлэсэн 2015Artigo -
6
Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001 -н George D. Demetri, Luis Paz‐Ares, Anna F. Farago, Stephen V. Liu, Sant P. Chawla, Diégo Tosi, E.S. Kim, Collin M. Blakely, John C. Krauss, Darren Sigal, Lyudmila Bazhenova, Thomas John, Benjamin Besse, J. Wolf, Takashi Seto, Edna Chow‐Maneval, Pratik S. Multani, Ann Johnson, Brian Simmons, Robert C. Doebele
Хэвлэсэн 2018Artigo -
7
OA02.01 Efficacy and Safety of Entrectinib in Locally Advanced or Metastatic ROS1 Fusion-Positive Non-Small Cell Lung Cancer (NSCLC) -н Robert C. Doebele, Myung‐Ju Ahn, Salvatore Siena, Alexander Drilon, Matthew Krebs, Chung‐Wu Lin, Filippo de Braud, Thomas John, Daniel Shao-Weng Tan, Takashi Seto, Rafał Dziadziuszko, Hendrik‐Tobias Arkenau, Fabrice Barlési, Christian Rolfo, Juergen Wolf, Edna Chow‐Maneval, Pratik S. Multani, Na Cui, Todd Riehl, B.C. Cho
Хэвлэсэн 2018Artigo -
8
Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer -н Anna F. Farago, Long P. Le, Zongli Zheng, Alona Muzikansky, Alexander Drilon, Manish R. Patel, Todd M. Bauer, Stephen V. Liu, Sai‐Hong Ignatius Ou, David M. Jackman, Daniel B. Costa, Pratik S. Multani, Gary G. Li, Zachary Hornby, Edna Chow‐Maneval, David Luo, Jonathan E. Lim, A. John Iafrate, Alice T. Shaw
Хэвлэсэн 2015Artigo -
9
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement -н Edward S. Kim, Suanna S. Bruinooge, Samantha Roberts, Gwynn Ison, Nancy U. Lin, Lia Gore, Thomas S. Uldrick, Stuart M. Lichtman, Nancy Roach, Julia A. Beaver, Rajeshwari Sridhara, Paul J. Hesketh, Andrea Denicoff, Elizabeth Garrett‐Mayer, Eric H. Rubin, Pratik S. Multani, Tatiana M. Prowell, Caroline Schenkel, Marina Kozak, Jeffrey C. Allen, Ellen V. Sigal, Richard L. Schilsky
Хэвлэсэн 2017Artigo -
10
ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms -н Kasey L. Couts, Judson Bemis, Jacqueline A. Turner, Stacey M. Bagby, Danielle Murphy, Jason Christiansen, Jennifer D. Hintzsche, Anh T. Le, Todd M. Pitts, Keith Wells, Allison Applegate, Carol M. Amato, Pratik S. Multani, Edna Chow‐Maneval, John J. Tentler, Yiqun G. Shellman, Matthew J. Rioth, Aik Choon Tan, René González, Theresa Medina, Robert C. Doebele, William A. Robinson
Хэвлэсэн 2017Artigo -
11
A Phase I/Ib Trial of the VEGFR-Sparing Multikinase RET Inhibitor RXDX-105 -н Alexander Drilon, Siqing Fu, Manish R. Patel, Marwan Fakih, Ding Wang, Anthony J. Olszanski, Daniel Morgensztern, Stephen V. Liu, Byoung Chul Cho, Lyudmila Bazhenova, Cristina P. Rodriguez, Robert C. Doebele, Antoinette Wozniak, Karen L. Reckamp, Tara Elisabeth Seery, Petros Nikolinakos, Zheyi Hu, Jennifer Oliver, Denise Trone, Katherine McArthur, Rupal Patel, Pratik S. Multani, Myung‐Ju Ahn
Хэвлэсэн 2018Artigo -
12
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor -н Christopher Alvarez‐Breckenridge, Julie J. Miller, Naema Nayyar, Corey M. Gill, Andrew Kaneb, Megan R. D’Andrea, Long P. Le, Jesse Lee, Ju Cheng, Zongli Zheng, William E. Butler, Pratik S. Multani, Edna Chow Maneval, Sun Ha Paek, Brian Toyota, Dora Dias‐Santagata, Sandro Santagata, Javier M. Romero, Alice T. Shaw, Anna F. Farago, Stephen Yip, Daniel P. Cahill, Tracy T. Batchelor, A. John Iafrate, Priscilla K. Brastianos
Хэвлэсэн 2017Artigo -
13
Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation -н Corey Cutler, Pratik S. Multani, David Robbins, Haesook T. Kim, Thuy Le, Jonathan Hoggatt, Louis M. Pelus, Caroline Desponts, Yi‐Bin Chen, Betsy Rezner, Philippe Armand, John Koreth, Brett Glotzbecker, Vincent T. Ho, Edwin P. Alyea, Marlisa Isom, Grace Kao, Myriam Armant, Leslie E. Silberstein, Peirong Hu, Robert J. Soiffer, David T. Scadden, Jerome Ritz, Wolfram Goessling, Trista E. North, John Mendlein, Karen K. Ballen, Leonard I. Zon, Joseph H. Antin, Daniel Shoemaker
Хэвлэсэн 2013Artigo -
14
What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) -н Alexander Drilon, G. Li, Snjezana Doğan, Mrinal M. Gounder, Ronglai Shen, Maria E. Arcila, L. Wang, David M. Hyman, Jaclyn F. Hechtman, Wei Ge, Nicholas Cam, Jason Christiansen, Lu Wang, Edna Chow Maneval, Todd M. Bauer, Minesh Patel, Stephen V. Liu, S.-H.I. Ou, Anna F. Farago, Alice T. Shaw, Robert Shoemaker, J. K. Lim, Zachary Hornby, Pratik S. Multani, Marc Ladanyi, Manfred Berger, Nora Katabi, Ronald Ghossein, Alan L. Ho
Хэвлэсэн 2016Artigo -
15
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1) -н Alexander Drilon, Salvatore Siena, Sai‐Hong Ignatius Ou, Manish R. Patel, Myung‐Ju Ahn, Jeeyun Lee, Todd M. Bauer, Anna F. Farago, Jennifer J. Wheler, Stephen V. Liu, Robert C. Doebele, Laura Giannetta, Giulio Cerea, Giovanna Marrapese, Michele Schirru, Alessio Amatu, Katia Bencardino, Laura Palmeri, Andrea Sartore‐Bianchi, Angelo Vanzulli, Sara Cresta, Silvia Damian, Matteo Duca, Elena Ardini, Gang Li, Jason Christiansen, Karey Kowalski, Ann Johnson, Rupal Patel, David Luo, Edna Chow‐Maneval, Zachary Hornby, Pratik S. Multani, Alice T. Shaw, Filippo de Braud
Хэвлэсэн 2017Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Medicine
Internal medicine
Cancer
Cancer research
Biology
Oncology
Lung cancer
Malignant pleural effusion
Receptor
Adenocarcinoma
Clinical trial
Crizotinib
Gene
Neurotrophin
Pathology
ROS1
Trk receptor
ALK inhibitor
Anaplastic lymphoma kinase
Genetics
Immunology
Adverse effect
Astrobiology
Biotechnology
Environmental health
Gene rearrangement
In vivo
Phases of clinical research
Physics
Population